论文部分内容阅读
江苏正大天晴药业自创建以来,一直注重完善企业自身技术创新体系的建设,不断提高企业自主创新能力,以科技创新带动产品创新。2006年,正大天晴药业的研发投入近6000万元,占销售收入的8%。与跨国企业动辄几十亿美元的研发投入相比,正大天晴药业几千万元的研发投入虽然微不足道,但由于专攻肝药研发领域,有利于企业做精做强。尤其是推行了研发“五维模式”后,带动了政府、企业、高校、
Since its establishment, Jiangsu CTT Pharmaceutical has been focusing on perfecting the construction of its own technological innovation system and continuously improving the capability of independent innovation of enterprises, and has driven product innovation through technological innovation. In 2006, R & D investment in Chia Tai Pharmaceutical nearly 60 million yuan, accounting for 8% of sales. Compared with the multi-billion dollar R & D investment of transnational enterprises, the R & D investment of Chia Tai Pharmaceutical tens of millions of dollars is insignificant. However, due to its specialization in the field of R & D of liver medicine, it is good for enterprises to become stronger and stronger. In particular, the implementation of R & D “five-dimensional model ”, led the government, enterprises, universities,